Medical Management of HIV Among Transgender Adults

Slides:

Advertisements

Similar presentations

No one left behind: Increased coverage, better programmes and maximum impact for key populations WHO Consolidated Guidelines on HIV Prevention, Diagnosis,

Advertisements

Key Populations 18 September 2013 Béchir N’Daw, Conseiller régional en Droits de l’Homme et aux Lois, PNUD.

Disease State Management The Pharmacist’s Role

SPECTRUM OF CARE ENGAGEMENT-ARIZONA PREVALENT CASES 2012 Note: HIV infected is derived using CDC’s national infection estimation guidelines.

HIV in Texas: The Ways Forward Ann Robbins Manager of HIV/STD Prevention and Care Department of State Health Services.

Nationals HIV/AIDS Strategy and how the mission of Women Accepting Responsibility, Inc. is helping to meet this goal. By She’kell Hutchinson Program Director,

HIV PREVENTION AND SUPPORTIVE SERVICES FOR LATINA WOMEN: A GRANT PROPOSAL PROJECT LIZETT MORALES CALIFORNIA STATE UNIVERSITY, LONG BEACH MAY 2013.

1 in+care Campaign Meet the Author November 12, 2013.

HIV/AIDS and Substance Use Disorders Olivera J. Bogunovic, M.D. State University of New York at Buffalo Alcohol Medical Scholars Program.

HIV and Behavioral Health: An Update from SAMHSA Elinore F. McCance-Katz, MD, PhD Chief Medical Officer Substance Abuse and Mental Health Services Administration.

Bheki Sithole 30 Nov Sibayeni Lodge Most at Risk Behavior Populations (MSM): Feedback, Challenges and Experiences.

Factors Associated with HIV Viral Load Suppression among HIV-positive Adults in Care in Washington State in 2009 Council of State and Territorial Epidemiologists.

Stepping up from Vulnerability to Opportunity: HIV and AIDS in the Global Context of African and Black Migrant and Diaspora Populations The Messenger Matters.

Family Medicine Residency of Idaho HIV Training Track.

PREVENTION OF MOTHER-TO-CHILD TRANSMISSION OF HIV WHAT’S NEW Prepared by Dr. Debbie Carrington National HIV/AIDS Prevention & Control Programme Ministry.

Morbidity Monitoring Project Data for Resource Planning and Evaluation A.D. McNaghten Centers for Disease Control and Prevention.

Racial Disparities in Antiretroviral Therapy Use and Viral Suppression among Sexually Active HIV-infected Men who have Sex with Men— United States, Medical.

HIV Treatment and Care Research priorities Facilitator – Dr Saphonn Vonthanak 12 participants 29 agreed topics –not grouped on methodology or subject category.

©2007 Walgreen Co. All rights reserved. 1 Patient Focused ADAP Programs Glen Pietrandoni, R.Ph December 4, 2008 ©2007 Walgreen Co. All rights reserved.

Interamerican College of Physicians and Surgeons.

Clinical Pharmacy Part 2

Division of HIV/AIDS Prevention CDC-RFA-PS

HIV Care Continuum New Diagnoses, 2011, Fulton County, Georgia.

HIV Care Continuum Persons Living With HIV, Georgia, 2012.

2014 HIV.STD.TB.Viral Hepatitis Symposium. Program Staff Lindsey VanderBusch – Program Manager Sarah.

SOUTH CAROLINA EPIDEMIOLOGIC PROFILE What is the Epi Profile? The HIV/AIDS Epidemiologic Profile is a document that: Describes the HIV/AIDS epidemic.

Gender in the Hospital Kaitlin Hollander 3/11/15 CCRMC Behavioral Medicine.

Key Affected Populations in Asia: Where are we and what is the way forward? Dr. Sai Subhasree Raghavan SAATHII, India Governing Council Member, IAS.

Mean HIV viral load among resident cases and undiagnosed in Oregon Jeff Capizzi, Epidemiologist Sean Schafer, HIV/STD/TB Medical Epidemiologist Lea Bush,

HIV Care Continuum New Diagnoses, 2011, Georgia. Persons with HIV Engaged in Selected Stages of the Continuum of Care, United States Percent

Looking Ahead to MTN-017 Ross D. Cranston MD, FRCP Microbicide Trials Network IRMA.

Results from the STEAM Survey Elizabeth Barash, MPH.

HIV Prevention: A Winnable Battle Centers for Disease Control and Prevention.

HIV Prevention for Transgender Populations JAIDS Supplement Launch Tonia Poteat, PhD, MPH, PA-C Johns Hopkins School of Public Health Baltimore, Maryland,

Integrated Epidemiologic Profiles for HIV Prevention and Care Planning Anna Satcher Johnson Stacy Cohen HIV Incidence and Case Surveillance Branch Division.

end+disparities Learning Exchange Part II: Subpopulations

HIV Care Continuum Ryan White Program - Miami-Dade County

PrEP for HIV Prevention

Gender-affirming hormones and antiretroviral therapy: implications on adherence and clinical outcomes Asa Radix, MD, MPH, FACP Director of Research and.

Focus on Providers: Identifying and Training PrEP Providers

TransIT The Transgender Implementation Tool for the WHO key population guidelines.

Engaging with Trans Women living with HIV

Maia Pinsky, MD-R3 Family Medicine Residency of Idaho

2017 Key Considerations for adolescents and children & Key populations

Current harm reduction program at outreach

Status Neutral: The New Normal for HIV

What are the Opportunities and Challenges?

Believed discrimination occurred because of their:

HIV and the ART of Prevention

Time to Focus: Doing Things Better and Differently for Transgender People Rena Janamnuaysook Thai Red Cross AIDS Research Centre, USAID LINKAGES, Thailand.

Managing Women Living With HIV Infection

Stacey A. Rizza, MD, Robin J. MacGowan, MPH, David W

Stopping the Epidemic HIV Prevention Today

Patient-Centered Care in Cystic Fibrosis

THAC0204 Integrated Gender Affirmative Hormone Treatment Services Improve Access to and Retention in HIV Testing, Syphilis Testing, and PrEP Service Uptake.

Chapter 21 Sexually Transmitted Infections and HIV/AIDS

Case Study. Managing Medication and Adherence in SIHD: Partnering With the Patient to Improve Care.

The cost-effectiveness of HIV pre-exposure prophylaxis in high-risk men who have sex with men and transgendered women in Brazil Paula M. Luz, Ben Osher,

A Brief Introduction: Violence and PEPFAR

ART Options and Treatment Decisions for Women of Reproductive Potential

Needs Assessment Slides for Module 4

Updates From CROI 2019: Treatment of HIV and Its Complications

Older adults should not have sex

Impact of Tenofovir Chemoprophylaxis on HIV Prevention Programs Questions and Implications from Local Experience Charles L. Henry, Director County of Los.

2025 AIDS targets Technical meeting on prevention

Reshmie Ramautarsing, M.D., Ph.D.

Updates From the International AIDS Conference (IAS 2019)

Managing Syphilis in HIV Co-infected Patients: A Case-Based Approach

PrEP Education and Counseling in a Title X Setting

March 8, 2006 New ACIP Hepatitis B Recommendations

Presentation transcript:

Medical Management of HIV Among Transgender Adults

Medical Management of HIV Among Transgender Adults

CME Information

Nursing and Pharmacy Credits

Evaluations will be available in your IAS-USA My Activities page by 5 pm PT today. See the IAS–USA website for instructions on claiming CME, pharmacy, nursing, or pharmacotherapy credits, or a certificate of participation.

Grant Support for this Webinar

Navigating the Webinar

Poll 1

Poll 2

Poll 3

Medical Management of HIV Among Transgender Adults

Financial Relationships With Commercial Entities

Learning Objectives

Pretest Question 1

Pretest Question 2

Definitions

U.S. Transgender Population Size Estimates

Ascertaining Gender Identities

Estimated Prevalence of HIV and Sexual Behaviors in US Trans Population: A Systematic Review and Meta-Analysis, 2006-2017

Clients Served by the Ryan White HIV/AIDS Program, by Gender and Race/Ethnicity, 2017—United States and 3 Territoriesa

Viral Suppression among Clients Served by the Ryan White HIV/AIDS Program, by Gender, 2017—United States and 3 Territoriesa

Gender Affirmation and HIV Care

Provider Interactions and Viral Suppression

Provider Interactions and Viral Suppression

Provider Interactions and Viral Suppression

Gender-Affirmation (also called “transition”)

Binding, Tucking, Soft Tissue Fillers (Silicone)

Medical and Surgical Gender Affirmation

Clinical Guidelines and Standards of Care

CASE: Brittany

ARS 1: What do you need to do to meet her needs?

Initial Visits: Medical History and Labs

Sexual History

Initial Visits: Physical Exam

Feminizing Regimens: Estrogen + Anti-androgen

Effects of Feminizing Hormones

Cardiovascular Health

Cardiovascular Health

Bone Health

Bone Health

Case 2: Rodney

ARS 2: Does Rodney need additional testing before starting ART?

Masculinizing Hormone Regimens

Masculinizing Therapy

Hormone Therapy Monitoring

Interpreting Sex-Based Lab Values

Interpreting Sex-Based Lab Values (2)

Interpreting Sex-Based Risk Estimates

Case 3: Marta

ARS 3: What is a potential cause of Marisa’s hot flashes?

Drug – Drug Interactions

ART and Gender Affirming Hormone Therapy Interactions

Drug Interaction Concerns Affect Adherence

PrEP in Transgender Women: iPrEx

PrEP in Transgender Women: iPrEx

PrEP in Transgender Women: iPrEx

Sex hormones alter TDF/FTC Pharmacology

Sex hormones alter TDF/FTC Pharmacology in HIV

The iFACT study

The iFACT study

Summary of Data on PrEP among Trans Women

Summary of Data on PrEP among Trans Women

Little data on PrEP for Trans Men

I-BrEATHe study (UCSF)

CDC Recommendations for PrEP

PrEP for Trans People: Take Home

PrEP for Trans People: Take Home

PrEP for Trans People: Take Home

PrEP for Trans People: Take Home

Stigma is a Barrier to Engagment

Trans-Affirming Clinic Environments

Trans-Affirming Clinic Environments

Trans-Affirming Clinic Environments

Trans-Affirming Clinic Environments

Trans-Affirming Clinic Environments

Resources

Posttest Question 1

Posttest Question 2

Question-and-Answer

Evaluations will be available in your IAS-USA My Activities page by 5 pm PT today. See the IAS–USA website for instructions on claiming CME, pharmacy, nursing, or pharmacotherapy credits, or a certificate of participation.

Final Poll

Sexual Health, HIV Prevention, and Primary Care in 2019

Thank You